Bausch Health Companies Inc. (TSE:BHC – Free Report) – Zacks Research increased their Q2 2024 EPS estimates for Bausch Health Companies in a research note issued on Tuesday, June 25th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $1.18 for the quarter, up from their prior estimate of $1.17. The consensus estimate for Bausch Health Companies’ current full-year earnings is $4.85 per share. Zacks Research also issued estimates for Bausch Health Companies’ Q3 2024 earnings at $1.41 EPS, FY2024 earnings at $4.90 EPS and Q4 2025 earnings at $1.78 EPS.
Bausch Health Companies (TSE:BHC – Get Free Report) last posted its earnings results on Thursday, May 2nd. The company reported C$0.80 earnings per share for the quarter, missing analysts’ consensus estimates of C$1.02 by C($0.22). The business had revenue of C$2.90 billion during the quarter, compared to analysts’ expectations of C$2.98 billion. Bausch Health Companies had a negative net margin of 5.07% and a negative return on equity of 686.52%.
Bausch Health Companies Stock Up 1.3 %
Bausch Health Companies Company Profile
Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.
Recommended Stories
- Five stocks we like better than Bausch Health Companies
- Stock Analyst Ratings and Canadian Analyst Ratings
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- 3 Ways To Invest In Coffee, Other Than Drinking It
- MarketBeat Week in Review – 6/24 – 6/28
- How to Calculate Options Profits
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.